From Tol2Kit
Line 1: | Line 1: | ||
Here is a list of the constructs in the Tol2kit. | Here is a list of the constructs in the Tol2kit. | ||
− | |||
Sequences and maps coming Real Soon Now. | Sequences and maps coming Real Soon Now. | ||
− | '''Constructs in the Tol2kit v1 ( | + | '''Constructs in the Tol2kit v1 (Feb 2007)''' |
− | |||
− | |||
{| border="1" | {| border="1" | ||
Line 31: | Line 28: | ||
|- | |- | ||
!228||p5E-MCS | !228||p5E-MCS | ||
− | |multi-cloning site from | + | |multi-cloning site from pBluescript||BM |
|- | |- | ||
!381||p5E-Fse-Asc | !381||p5E-Fse-Asc | ||
Line 90: | Line 87: | ||
! colspan="4" style="background:#ffdead;" |destination vectors, attR4-R3 (amp/chlor resistant; grow in ccdB-tolerant cells) | ! colspan="4" style="background:#ffdead;" |destination vectors, attR4-R3 (amp/chlor resistant; grow in ccdB-tolerant cells) | ||
|- | |- | ||
− | !392||pDestTol2pA | + | !392||pDestTol2pA* |
|attR4-R3 gate with SV40 polyA flanked by Tol2 inverted repeats||CG | |attR4-R3 gate with SV40 polyA flanked by Tol2 inverted repeats||CG | ||
|- | |- | ||
− | !393||pDestTol2CG | + | !393||pDestTol2CG* |
|pDestTol2pA with cmlc2:egfp transgenesis marker||EF | |pDestTol2pA with cmlc2:egfp transgenesis marker||EF | ||
|- | |- | ||
Line 108: | Line 105: | ||
|for in vitro transcription of capped Tol2 transposase mRNA||KMK | |for in vitro transcription of capped Tol2 transposase mRNA||KMK | ||
|} | |} | ||
+ | '''Notes''' | ||
+ | * '''#''' is the Chien lab stock number | ||
+ | * '''made by''' shows who made the construct: | ||
+ | ** CG: Clemens Grabher, Look lab | ||
+ | ** BM: Ben Mangum, Chien lab | ||
+ | ** DSC, Doug Campbell, Chien lab | ||
+ | ** EF, Esther Fujimoto, Chien lab | ||
+ | ** KMK, Kristen Kwan, Chien lab | ||
+ | ** MEH, Melissa Hardy | ||
+ | * pDestTol2pA and pDestTol2CG have been superseded by pDestTol2pA2 and pDestTol2CG2, and are no longer being distributed. |
Revision as of 13:03, 2 February 2007
Here is a list of the constructs in the Tol2kit. Sequences and maps coming Real Soon Now.
Constructs in the Tol2kit v1 (Feb 2007)
# | name | insert | made by |
---|---|---|---|
5' entry clones, attL4-R1 (kan resistant) | |||
299 | p5E-bactin2 | 5.3 kb beta-actin promoter (ubiquitous) | KMK |
380 | p5E-h2afx | 1 kb histone2A-X promoter (quasi-ubiquitous) | KMK |
382 | p5E-CMV/SP6 | 1 kb CMV/SP6 cassette from pCS2+ | KMK |
222 | p5E-hsp70 | 1.5 kb hsp70 promoter for heat-shock induction | BM |
327 | p5E-UASE1B | 10x UAS element and basal promoter for Gal4 response | DSC |
228 | p5E-MCS | multi-cloning site from pBluescript | BM |
381 | p5E-Fse-Asc | restriction sites for 8-cutters FseI and AscI | EF |
middle entry clones, attL1-L2 (kan resistant) | |||
383 | pME-EGFP | EGFP | KMK |
384 | pME-EGFPCAAX | membrane-localized (prenylated_ EGFP; fused to 21 aa of H-ras | KMK |
385 | pME-nlsEGFP | nuclear-localized EGFP | KMK |
386 | pME-mCherry | monomeric red fluorophore mCherry | KMK |
232 | pME-mCherryCAAX | prenylated mCherry | KMK |
233 | pME-nlsmCherry | nuclear-localized mCherry | KMK |
234 | pME-H2AmCherry | mCherry fused to zebrafish histone H2A.F/Z | KMK |
387 | pME-Gal4VP16 | Gal4 DNA binding domain fused to VP16 transactivation domain | KMK |
3' entry clones, attR2-L3 (kan resistant) | |||
302 | p3E-polyA | SV40 late polyA signal | KMK |
229 | p3E-MTpA | 6x myc tag for C-terminal fusions, plus SV40 late polyA | BM |
366 | p3E-EGFPpA | EGFP for C-terminal fusions, plus SV40 late polyA | MEH |
388 | p3E-mCherrypA | mCherry for C-terminal fusions, plus SV40 late polyA | MEH |
389 | p3E-IRES-EGFPpA | IRES driving EGFP plus SV40 late polyA | KMK |
390 | p3E-IRES-EGFPCAAXpA | IRES driving prenylated EGFP plus SV40 late polyA | KMK |
391 | p3E-IRES-nlsEGFPpA | IRES driving nuclear EGFP plus SV40 late polyA | KMK |
destination vectors, attR4-R3 (amp/chlor resistant; grow in ccdB-tolerant cells) | |||
392 | pDestTol2pA* | attR4-R3 gate with SV40 polyA flanked by Tol2 inverted repeats | CG |
393 | pDestTol2CG* | pDestTol2pA with cmlc2:egfp transgenesis marker | EF |
394 | pDestTol2pA2 | pDestTol2pA with ~2 kb extraneous sequence removed | EF |
395 | pDestTol2CG2 | pDestTol2CG2 with ~2 kb extraneous sequence removed | EF |
transposase clones | |||
396 | pCS2FA-transposase | for in vitro transcription of capped Tol2 transposase mRNA | KMK |
Notes
- # is the Chien lab stock number
- made by shows who made the construct:
- CG: Clemens Grabher, Look lab
- BM: Ben Mangum, Chien lab
- DSC, Doug Campbell, Chien lab
- EF, Esther Fujimoto, Chien lab
- KMK, Kristen Kwan, Chien lab
- MEH, Melissa Hardy
- pDestTol2pA and pDestTol2CG have been superseded by pDestTol2pA2 and pDestTol2CG2, and are no longer being distributed.